Surface replacing arthroplasty of the proximal interphalangeal joint using the CapFlex-PIP implant: a prospective study with 5-year outcomes.


Journal

The Journal of hand surgery, European volume
ISSN: 2043-6289
Titre abrégé: J Hand Surg Eur Vol
Pays: England
ID NLM: 101315820

Informations de publication

Date de publication:
Jun 2021
Historique:
pubmed: 4 12 2020
medline: 10 8 2021
entrez: 3 12 2020
Statut: ppublish

Résumé

The purpose of this prospective study was to evaluate the 5-year outcomes in patients after proximal interphalangeal joint arthroplasty using the surface replacing implant, CapFlex-PIP. Ninety-two prosthesis were implanted and 65 patients with 68 implants were available for follow-up. The brief Michigan Hand Outcomes Questionnaire score improved significantly from 45 (SD 15) before surgery to 71 (SD 17) at 5 years. On the numeric rating scale, pain during activities decreased significantly from 6.4 (SD 1.9) to 1.8 (SD 1.9). Range of motion of the joints increased significantly from 45° (SD 21) to 54° (SD 24). An axis deviation of more than 5° was found in 65% of the joints before surgery, but only in 25% at 5 years. Soft tissue reoperations were performed on eight patients. Four out of 92 implants underwent revision for stiffness or implant loosening. In three implants, the distal component migrated without needing revision. Overall, the CapFlex-PIP implant demonstrates favourable medium-term results in surface replacing arthroplasty of the proximal interphalangeal joint.

Identifiants

pubmed: 33270488
doi: 10.1177/1753193420977244
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

496-503

Auteurs

Vanessa Reischenböck (V)

Department of Hand Surgery, Schulthess Klinik, Zurich, Switzerland.

Miriam Marks (M)

Department of Teaching, Research and Development, Schulthess Klinik, Zurich, Switzerland.

Daniel B Herren (DB)

Department of Hand Surgery, Schulthess Klinik, Zurich, Switzerland.

Stephan Schindele (S)

Department of Hand Surgery, Schulthess Klinik, Zurich, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH